BioSpace News Archive

The active component of the drug, sodium valproate, has been on the market for epilepsy and bipolar disorder since 1967.

Following a court’s ruling last week over a partial clinical hold placed on the company in 2018 by the U.S. Food and Drug Administration, Vanda Pharmaceuticals said it is undertaking a “comprehensive review” of the decision and will then determine the next appropriate steps.

“Anteros Pharmaceuticals is the first of several companies that BioMotiv and Bristol-Myers Squibb intend to form under the Strategic Partnership Agreement,” said Satish Jindal, BioMotiv’s chief executive officer.

Pattern Bioscience was awarded funding from CARB-X to develop a new rapid diagnostic for drug-resistant bacterial infection.

“We have successfully engineered a new molecule, which is a modified sugar that shows broad-spectrum antiviral properties,” said Samuel Jones, from The University of Manchester.

The National Institutes of Health ceased administration of an investigational HIV vaccine after interim data revealed that the treatment was not working in preventing the virus.

Your organization needs to figure out how to come up with ideas for cultivating diversity and inclusion in the workplace.

Samsung Biologics, a pharmaceutical Contract Manufacturing Organization, recorded high for the fiscal year 2019, reporting 30.9% growth in sales at 701.6 billion won, and 64.6% growth in operating profit at 91.7 billion won compared to the previous year.

Demonstrating business momentum with FY2019 Q3 year-to-date (YTD) revenue 2,519.5 billion yen, up +82.6% versus prior year due to acquisition of Shire and continued strong performance of 14 global brands; while Underlying Revenue expected to recover in Q4 resulting in flat to slightly increasing for the full year

Bactiguard deepens the partnership that was initiated in 2015 by acquiring Vigilenz Medical Devices and Vigilenz Medical Supplies in Malaysia.